Antonella Millin

Interventional cardiologist / Cardiologist
Montefiore Medical Center - New York, United States of America

Latest contributions

Lessons learned to pave the way for future-proof strategies in TAVI

20 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session focuses on how current experience in transcatheter aortic valve implantation (TAVI) can be translated into more durable strategies for the future, particularly in patients with bicuspid aortic valve disease.

It provides a comprehensive overview of anatomical, clinical, and procedural considerations in this challenging...

Lessons learned to pave the way for future-proof strategies in TAVI

Optimising bifurcation PCI: learning from randomised controlled trials

20 May 2026 – From EuroPCR 2026

This session delves into optimizing bifurcation PCI by examining contemporary European practices and outcomes from multiple randomized controlled trials. Key topics include multivessel TALENT trial results, 30-day outcomes of left main PCI with sirolimus-eluting stents from the NAGOMI COMPLEX study, comparative insights from the CROSS-LCX Registry...

Management of a patient with complex multivessel disease involving bifurcations

19 May 2026 – From EuroPCR 2026

Complex multivessel coronary disease involving bifurcations requires careful procedural planning, imaging guidance and tailored stent strategies.

This EuroPCR 2026 session combines live educational case with insights from the NAGOMI COMPLEX study to explore contemporary approaches to complex PCI. A key focus is placed on the role of...

Management of a patient with complex multivessel disease involving bifurcations

Innovation to address unmet clinical needs in transcatheter valve therapies

22 May 2025 – From EuroPCR 2025

Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.

Innovation to address unmet clinical needs in transcatheter valve therapies

Featured Cases - Challenging mitral TEER (Part 2)

25 Nov 2024 – From PCR London Valves 2024

Explore a collection of challenging mitral transcatheter edge-to-edge repair (M-TEER) cases in this featured session. Gain insights into managing severe mitral regurgitation in an octogenarian with Barlow's syndrome, tackling the A1 prolapse, performing TEER for mitral valve prolapse at the commissure, and addressing severe mitral regurgitation...

Featured Cases - Challenging mitral TEER (Part 2)

Rapid-fire - Transcatheter solutions for rare complications

24 Nov 2024 – From PCR London Valves 2024

Prepare to be captivated by a rapid-fire session showcasing transcatheter solutions for rare and complex cardiovascular complications. Witness the percutaneous closure of a right ventricular pseudo-aneurysm, the treatment of a VSD complicating myocardial infarction, and the management of iatrogenic left ventricular pseudo-aneurysms. Explore innovative approaches to...

Rapid-fire - Transcatheter solutions for rare complications